H
Huamei Haolian Medical Technology
Health Tech & Medtech · China
AI-powered digital health management solutions for insurers. MoreLess
Huamei Haolian Medical Technology (also known as E-Health Now) is a one-stop artificial intelligence digital health service technology group founded in 2017 by CEO Xu Bingyu. The company, with headquarters in Suzhou and an operations center in Beijing, has established a presence in major Chinese cities and the United States. Through a B2B2C business model, it provides health management service solutions and digital empowerment for clients in the insurance, banking, and corporate sectors.
The company's core services leverage AI technology and integrated medical resources to offer full-cycle health management, spanning pre-diagnosis, in-diagnosis, and post-diagnosis phases. Huamei Haolian has developed proprietary AI products such as "AI General Practitioner" and "AI Precise Medical Treatment," launched in 2022. Its core algorithms for "precise medical treatment" and "TCM inquiries" have received official备案 (bèi àn, record-filing) in the precision medicine field, and its health management large model has completed national-level generative AI service备案, positioning it as a compliant provider of large-scale AI applications.
Huamei Haolian provides a range of services including online consultations, video doctor appointments, green channel access for medical treatment, international multi-disciplinary consultations, and access to specialty drugs. As of early 2026, the company's network includes over 1,650 Grade-A tertiary hospitals in China and partnerships with more than 300 domestic medical institutions. It also has links to 8 international medical systems and nearly 3,000 international experts. The firm has served nearly 300 B2B clients and over 56 million end-users.
The company has secured significant funding through multiple rounds. A Series C round in July 2024 raised nearly 100 million yuan from investors including Amiba Capital, Ventech China, and Fengqiao Capital. This was followed by a Series D round of several hundred million yuan in March 2026, co-led by Yifeng Capital, YHLO, Ventech China, and Fengqiao Capital, with participation from Oriental Fortune Capital, GSR Ventures, and a Tongji University alumni fund.
Keywords: E-Health Now, digital health, AI medical, health management, B2B2C, insurtech, online consultation, video doctor, precision medicine, health data, AI algorithms, healthcare platform, corporate wellness, insurance services, medical network, healthcare technology, telemedicine, digital therapeutics, AI diagnostics
Company overview
Huamei Haolian Medical Technology company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- —
- Headquarters
- China
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 13.6
Valuation & funding
Huamei Haolian Medical Technology funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | Mar 2026 | $28M | $110M | Ventech China · Shenzhen Yahuilong Biotechnology · Tongji Alumni Fund · GSR Ventures China | ↗ |
| SERIES C✓Equity / VC | Sep 2025 | $0 | — | Yuanyi Capital · CDH Investments | ↗ |
| SERIES C✓Equity / VC | Jul 2024 | $14M | $55M | Ameba Capital · Borchid Capital · Ventech China | ↗ |
| SERIES B✓Equity / VC | May 2023 | $2.8M | $11M | GSR Ventures · Tongji Alumni Fund · Ventech China · Langrun Investment | ↗ |
| SERIES A✓Equity / VC | Aug 2022 | $2.8M | $11M | Borchid Capital · Tongji Alumni Fund | ↗ |
| SERIES A✓Equity / VC | Jun 2022 | GSR Ventures · Ventech China | — |
Growth signals
Huamei Haolian Medical Technology website traffic
Latest recorded traffic for Huamei Haolian Medical Technology is 1.7K monthly website visits, up 1316.7% over the last three months.
Comparisons
Huamei Haolian Medical Technology compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Huamei Haolian Medical Technology's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Huamei Haolian Medical Technology has talent and traffic
In the news
Latest news about Huamei Haolian Medical Technology
Recent press, funding announcements, and product moves mentioning Huamei Haolian Medical Technology — open to read from the original sources.
Market sentiment
What the market is saying about Huamei Haolian Medical Technology
An AI-synthesized read of the highest-engagement posts about Huamei Haolian Medical Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Huamei Haolian Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.













